A new study, released by the US Food and Drug Administration, reviewed the medical history of more than 800,000 women who were taking different forms of birth control between 2001 and 2007. Data from the research revealed that women who were taking Yasmin had a 75% greater chance of experiencing a blood clot than women taking older birth control drugs. According to the study, the medication contains estrogen along with a next-generation synthetic hormone called drospirenone, which is known to increase the levels of potassium that are present in the blood. The FDA compared the medical records of females that took Yasmin with those who were on the older drug levonorgestrel.
Yasmin and related drospirenone-containing pills were Bayer’s second-best-selling franchise last year, bringing in $1.6 billion in global sales for the pharmaceutical giant. Dr. Diana Zuckerman, president of the National Center for Women and Families, a consumer group for women’s health issues, told the AP:
At a certain point we have to ask why the FDA continues to approve drugs that are less safe and have no benefit compared to drugs already on the market. With all these different birth control options, why take the most expensive one that can also kill you?
Associated Press reported that a study involving more than 1 million Danish women found that Yasmin and other new medications had twice the risk of blood clots as women taking the older medication. This data was published in the British Medical Journal. The International Business Times reported that Bayer came out against the publication of the FDA study. The pharmaceutical company disagreed with the data and argued that it spent significant amounts of money to test these drugs. Bayer claimed that the authors applied the study methodology reported in the two publications and the databases used provided less reliable conclusions than are available from existing scientific evidence around the risk of developing venous thromboembolism (blood clots), with combination oral contraceptives.
If you need additional information on this subject contact Leigh O’Dell or Chad Cook, lawyers in our firm, at 800-898-2034 or by email at Leigh.Odell@beasleyallen.com or Chad.Cook@beasleyallen.com. Leigh and Chad have been heavily involved in this litigation.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.